Director notifies planned sale of TEVA ordinary shares

TEVA notice reports a proposed resale of 13,043 ordinary shares tied to a restricted share unit award vesting on 06/05/2026.

Rhea-AI Filing Summary

TEVA notice reports a proposed resale of 13,043 ordinary shares tied to a restricted share unit award vesting on 06/05/2026. The filing also records a prior sale of 20,025 ordinary shares on 03/05/2026 for $634,159.71.

Insights

Securities Compliance Counsel

Routine resale notice and past director sale; compliance-focused filing.

Form 144 is a regulatory notice for intended resale; the entry lists 13,043 shares tied to an RSU vesting event on 06/05/2026. The filing also records a past sale of 20,025 shares disposed on 03/05/2026 for $634,159.71.

Timing and sale mechanics are not detailed in the excerpt; subsequent Form 4 or broker confirmations would show execution details and actual proceeds received.

Key Figures

RSU-derived shares to be sold: 13,043 shares Shares sold in past 3 months: 20,025 shares Proceeds reported: $634,159.71 +1 more

4 metrics

RSU-derived shares to be sold 13,043 shares vesting on 06/05/2026

Shares sold in past 3 months 20,025 shares sale on 03/05/2026 by Richard Francis

Proceeds reported $634,159.71 consideration for 20,025 shares on 03/05/2026

Listing NYSE exchange indicated in excerpt

Key Terms

Restricted Share Unit, Form 144, Securities To Be Sold

3 terms

Restricted Share Unit financial

"RESTRICTED SHARE UNIT AWARD VESTING"

A restricted share unit (RSU) is a promise by a company to give an employee a set number of company shares at a future date, typically after meeting time or performance conditions. For investors, RSUs matter because when they convert into actual shares they increase the number of shares outstanding (like unlocking more tickets in a game), which can dilute existing holders, and they align employee incentives with company performance, influencing behavior and long-term value.

Form 144 regulatory

"form_type: "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does TEVA's Form 144 disclose about the 13,043 shares?

It states 13,043 ordinary shares are tied to a restricted share unit award vesting on 06/05/2026. The notice frames these shares as compensation‑related; the filing does not describe planned sale mechanics or expected proceeds in the provided excerpt.

Who sold shares in the past three months according to the filing?

Richard Francis is listed as having sold 20,025 ordinary shares on 03/05/2026 for $634,159.71. The entry records the transaction amount and date; additional transaction details would appear in related trading reports or broker records.

Does the Form 144 specify how the 13,043 vested shares will be sold?

The excerpt shows the shares are from an RSU vesting event but does not specify the method of sale. The filing lists the security and vesting date; sale method and timing are not provided in this excerpt.

Will TEVA receive proceeds from the sales listed in this Form 144?

The filing excerpt does not attribute proceeds to TEVA; the 03/05/2026 sale lists proceeds of $634,159.71 tied to Richard Francis. The notice format typically covers resale by holders rather than issuer proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 04:00 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001673277
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TEVA PHARMACEUTICAL INDUSTRIES LTD
SEC File Number	001-16174
Address of Issuer	TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV ISRAEL 6944020
Phone	972 (3) 914-8213
Name of Person for Whose Account the Securities are To Be Sold	Francis Richard D
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	PRESIDENT AND CEO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS INC 390 GREENWICH STREET NEW YORK NY 10013	6153	211355.55	1164426972	06/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	06/05/2025	RESTRICTED SHARE UNIT AWARD VESTING	TEVA PHARMACEUTICAL INDUSTRIES LIMITED			13043	06/05/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
RICHARD FRANCIS 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020	ORDINARY SHARES	03/05/2026	20025	634159.71

144: Remarks and Signature

Remarks	SECTION 3E SHARES OR OTHER UNITS OUTSTANDING BASED ON ORDINARY SHARES. SHARES WERE SOLD PURSUANT TO A 10B51 PLAN ESTABLISHED IN NOV 2025 TO COVER THE VESTING AND SETTLEMENT OF EQUITY AWARDS VIA SELL TO COVER OBLIGATIONS
Date of Notice	06/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	CONFORMED SIGNATURE ON FILE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)